Authors:
Bhol, KC
Desai, A
Kumari, S
Colon, JE
Ahmed, AR
Citation: Kc. Bhol et al., Pemphigus vulgaris: The role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production, CLIN IMMUNO, 100(2), 2001, pp. 172-180
Authors:
Sami, N
Bhol, KC
Beutner, EH
Plunkett, RW
Leiferman, KM
Foster, CS
Ahmed, AR
Citation: N. Sami et al., Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies, CLIN IMMUNO, 100(2), 2001, pp. 219-227
Authors:
Kumari, S
Bhol, KC
Rehman, F
Foster, CS
Ahmed, AR
Citation: S. Kumari et al., Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy, CYTOKINE, 14(4), 2001, pp. 218-224
Authors:
Kumari, S
Bhol, KC
Simmons, RK
Razzzaque, MS
Letko, E
Foster, CS
Ahmed, AR
Citation: S. Kumari et al., Identification of ocular cicatricial Pemphigoid antibody binding site(s) in human beta 4 integrin, INV OPHTH V, 42(2), 2001, pp. 379-385
Citation: N. Sami et al., Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses, CLIN EXP IM, 125(3), 2001, pp. 492-498
Citation: Kc. Bhol et al., Presence of interleukin 10 in the serum and blister fluid of patients withpemphigus vulgaris and pemphigoid, CYTOKINE, 12(7), 2000, pp. 1076-1083
Authors:
Engineer, L
Johnson, RE
Bhol, KC
Ahmed, AR
Citation: L. Engineer et al., Bovine gingival lysate: a novel substrate for rapid diagnosis of autoimmune vesiculobullous diseases - A preliminary observation, EXP DERMATO, 9(4), 2000, pp. 271-274
Citation: L. Engineer et al., Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris, J AM ACAD D, 43(6), 2000, pp. 1049-1057
Citation: Kc. Bhol et al., The autoantibodies to alpha(6)beta(4) integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta(4), J IMMUNOL, 165(5), 2000, pp. 2824-2829
Citation: Iu. Khan et al., Linear IgA bullous dermatosis in a patient with chronic renal failure: Response to intravenous immunoglobulin therapy, J AM ACAD D, 40(3), 1999, pp. 485-488